Bladder Cancer

Scope & Guideline

Unveiling breakthroughs in bladder cancer management.

Introduction

Explore the comprehensive scope of Bladder Cancer through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Bladder Cancer in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2352-3727
PublisherIOS PRESS
Support Open AccessYes
CountryNetherlands
TypeJournal
Convergefrom 2015 to 2024
AbbreviationBLADDER CANCER / Bladder Cancer
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressNIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'Bladder Cancer' focuses on advancing the understanding, diagnosis, treatment, and management of bladder cancer through rigorous research and clinical studies. It encompasses a broad range of topics that contribute to the field of urologic oncology.
  1. Clinical Research and Trials:
    The journal emphasizes clinical trials, including novel therapies, surgical techniques, and chemotherapy regimens, to provide evidence-based practices for treating bladder cancer.
  2. Biomarkers and Molecular Studies:
    Research on molecular subtypes, biomarkers, and genetic factors plays a crucial role in understanding bladder cancer pathogenesis and tailoring individualized therapies.
  3. Patient-Centered Approaches:
    The journal highlights studies focusing on patient decision-making, quality of life, and supportive care, recognizing the importance of patient experiences and preferences in treatment outcomes.
  4. Innovative Treatment Modalities:
    Exploration of new treatment strategies, including immunotherapy, targeted therapy, and advanced surgical techniques, reflects the journal's commitment to improving therapeutic options for bladder cancer patients.
  5. Epidemiology and Risk Factors:
    Investigations into the epidemiology, risk factors, and preventive measures related to bladder cancer are integral to understanding disease trends and improving public health initiatives.
The field of bladder cancer research is dynamic, with several emerging themes that have gained traction in recent publications. These trends indicate a shift towards more innovative and patient-focused approaches.
  1. Immunotherapy and Novel Therapeutics:
    A significant increase in studies focusing on immunotherapy, including checkpoint inhibitors and antibody-drug conjugates, highlights a trend towards utilizing the immune system to combat bladder cancer.
  2. Patient Quality of Life and Psychosocial Factors:
    Research exploring the quality of life, psychosocial impacts, and supportive care for bladder cancer patients is on the rise, emphasizing the importance of holistic approaches to treatment.
  3. Integration of Biomarkers in Clinical Practice:
    There is a growing trend towards integrating biomarker studies in clinical settings, enabling personalized medicine approaches that tailor treatments based on individual patient profiles.
  4. Real-World Evidence and Patient-Centric Research:
    Studies utilizing real-world data to assess treatment outcomes and patient experiences are increasingly prominent, reflecting a shift towards understanding the practical implications of treatment in diverse populations.
  5. Management of Non-Muscle Invasive Bladder Cancer (NMIBC):
    An emerging focus on the management strategies for NMIBC, including surveillance protocols and treatment innovations, indicates a need for more effective approaches in this prevalent disease category.

Declining or Waning

While the journal continues to thrive in many areas, certain themes have shown a decline in prominence over recent years. This may reflect shifting research priorities or advancements in other areas.
  1. Basic Science and Animal Studies:
    There has been a noticeable reduction in the publication of basic science and animal model studies, as the focus shifts towards clinical applications and human studies that directly impact patient care.
  2. Historical and Epidemiological Analyses:
    Research articles examining historical data or long-term epidemiological trends have become less frequent, possibly indicating a move towards more immediate clinical relevance and actionable findings.
  3. Traditional Chemotherapy Studies:
    The emphasis on traditional chemotherapy regimens has waned as newer therapies, particularly immunotherapies and targeted agents, gain traction in clinical practice, reflecting the evolving landscape of cancer treatment.

Similar Journals

Actas Urologicas Espanolas

Shaping the Future of Urology, One Study at a Time
Publisher: ELSEVIER ESPANAISSN: 0210-4806Frequency: 10 issues/year

Actas Urologicas Espanolas is a prestigious journal published by Elsevier España, dedicated to the field of Urology. Established in 1977, this journal has significantly contributed to advancing knowledge and research in urological medicine and surgery, spanning a comprehensive scope that includes clinical studies, surgical techniques, and the latest innovations in the treatment of urological diseases. With an impact factor reflecting its critical role in the academic community, it is ranked Q3 in the Urology category as of 2023, placing it amongst the valuable resources for professionals and researchers. The journal is indexed under Scopus, achieving a commendable rank of #70 out of 120 in the Medicine-Urology category, situating it within the 42nd percentile. As a significant platform for sharing advancements and findings, it encourages submissions that enhance urological care and improve patient outcomes. Although not an Open Access journal, the publication remains vital for those looking to stay updated on the latest developments in urology. For more details, visit their office located at CALLE DE ZURBANO, 76-4TH FLR LEFT, MADRID, 28010, SPAIN.

Breast Care

Shaping the Future of Oncology and Surgical Techniques
Publisher: KARGERISSN: 1661-3791Frequency: 6 issues/year

Breast Care is a prominent academic journal published by KARGER, focusing on the dynamic fields of oncology and surgery. With an ISSN of 1661-3791 and an E-ISSN of 1661-3805, this peer-reviewed journal has established itself as an essential resource for researchers, clinicians, and students dedicated to advancing breast health. Based in Switzerland, it benefits from a strong academic reputation, evident in its impressive Scopus rankings—placing it in the 79th percentile in Surgery (Rank #115/551) and the 53rd percentile in Oncology (Rank #188/404). The journal is recognized for its rigorous exploration of current trends, innovations, and challenges in breast care, encompassing a wide scope from surgical techniques to oncological therapies. With a Q2 ranking in Oncology and a notable Q1 ranking in Surgery as of 2023, Breast Care not only contributes to the advancement of medical knowledge but also fosters interdisciplinary collaboration among healthcare professionals worldwide.

ONCOLOGY

Connecting researchers and clinicians in the fight against cancer.
Publisher: KARGERISSN: 0030-2414Frequency: 12 issues/year

ONCOLOGY is a prestigious journal published by KARGER, dedicated to advancing the field of cancer research and treatment. Established in 1948, this peer-reviewed journal has established a significant presence in the medical community, reflected by its impressive impact factor and Q2 category rankings in both Cancer Research and Oncology as of 2023. With a focus on groundbreaking research and comprehensive reviews, ONCOLOGY serves as a crucial resource for researchers, clinicians, and students interested in the latest developments in the fight against cancer. Although it currently does not offer open access, the journal's reputation ensures that it reaches a wide audience in academia and clinical practice. Its commitment to excellence is underscored by its consistent rankings in key disciplines, making it a vital publication for anyone involved in cancer research, biology, or associated medical fields. The journal is headquartered in Basel, Switzerland, positioning it at the heart of European medical research.

Advances in Urology

Elevating Standards in Urological Care and Research
Publisher: HINDAWI LTDISSN: 1687-6369Frequency: 1 issue/year

Advances in Urology is a premier scholarly journal published by HINDAWI LTD that has been contributing to the field of urology and obstetrics since its establishment. With an impact factor reflecting its growing influence, this Open Access journal, available since 2008, ensures that researchers and professionals can readily access cutting-edge developments in urological health, surgical techniques, and innovative treatment methodologies. Based in the United States, the journal covers a wide array of topics relevant to urology and obstetrics, maintaining a notable presence in academic rankings, with a Q2 category designation in both fields as of 2023. The journal is indexed in Scopus, ranking #54 out of 120 in Urology and #95 out of 209 in Obstetrics and Gynecology, further adding to its credibility and reach. As it converges from 2009 to 2024, Advances in Urology continues to be a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions within these critical areas of medicine.

Journal of Clinical Urology

Elevating Standards in Urology and Surgical Medicine
Publisher: SAGE PUBLICATIONS LTDISSN: 2051-4158Frequency: 6 issues/year

The Journal of Clinical Urology, published by SAGE Publications Ltd, is a prominent academic platform dedicated to advancing the field of urology and surgical medicine. With an ISSN of 2051-4158 and an E-ISSN of 2051-4166, this journal has been pivotal in disseminating cutting-edge research since its inception in 2008 and is set to continue through 2024. Although categorized in the Q4 quartile for both Surgery and Urology, and positioned in the 24th and 22nd percentiles respectively according to Scopus rankings, the journal remains an essential resource for professionals, researchers, and students who seek to understand clinical developments and innovative practices in urological surgery. While the journal does not operate under an Open Access model, it provides critical insights and valuable findings that significantly impact healthcare practices and patient outcomes in the urology field.

Molecular and Clinical Oncology

Empowering breakthroughs in cancer biology and treatment.
Publisher: SPANDIDOS PUBL LTDISSN: 2049-9450Frequency: 12 issues/year

Molecular and Clinical Oncology is a dynamic journal published by SPANDIDOS PUBL LTD, aimed at advancing the understanding of cancer biology and treatment modalities. With an ISSN of 2049-9450 and an E-ISSN of 2049-9469, the journal serves as a critical platform for researchers and clinicians dedicated to uncovering novel insights in molecular oncology and enhancing clinical practices. As a testament to its growing influence, the journal has achieved a Q3 ranking in Oncology and a Q4 ranking in Cancer Research for the year 2023, reflecting its commitment to publishing high-quality research. Although currently not an Open Access publication, the journal offers crucial subscription options, ensuring comprehensive access to groundbreaking studies and innovations in the field. With converged years spanning 2018 to 2024, the journal is set to continue enriching the academic community with its valuable contributions, ultimately empowering researchers, professionals, and students engaged in the fight against cancer.

International Journal of Cancer Management

Empowering healthcare professionals with cutting-edge knowledge.
Publisher: BRIEFLANDISSN: 2538-4422Frequency: 12 issues/year

The International Journal of Cancer Management is a distinguished publication dedicated to advancing knowledge and research in the fields of cancer management, oncology, pharmacology, and radiology. Published by BRIEFLAND in the Netherlands, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the latest developments in cancer care and treatment strategies. With an ISSN of 2538-4422 and an E-ISSN of 2538-497X, the journal features a range of peer-reviewed articles that cover diverse aspects of cancer management, reflecting its commitment to high-quality, impactful research. The journal ranks in the Q4 category for Cancer Research and Oncology and Q3 for both Pharmacology and Surgery in 2023, signifying its growing influence in the scientific community. Through its open access format, the International Journal of Cancer Management ensures that critical research findings are accessible to all, promoting collaboration and innovation in the battle against cancer. Researchers looking to share their findings or learn more about current trends will find this journal an invaluable addition to their professional toolkit.

Indian Journal of Surgical Oncology

Bridging Research and Clinical Excellence in Oncology
Publisher: SPRINGER INDIAISSN: 0975-7651Frequency: 4 issues/year

The Indian Journal of Surgical Oncology, published by SPRINGER INDIA, is a vital source of scholarly research and discourse in the fields of oncology and surgery. Since its inception in 2010, the journal has been dedicated to advancing the science and practice of surgical oncology, providing a platform for researchers, clinicians, and educators to disseminate their findings and insights. With an increasing impact factor, the journal currently ranks in the Q4 category in Oncology and Q3 category in Surgery, reflecting its growing influence in the academic community. The journal maintains a focus on high-quality research, clinical studies, and innovative surgical techniques, fostering knowledge exchange among professionals in India and beyond. Although an open access option is not provided, the journal remains an essential repository of information for anyone engaged in the rapidly evolving fields of surgical oncology. For access to groundbreaking research and updates in the discipline, the Indian Journal of Surgical Oncology continues to be an indispensable resource.

Oncology Reviews

Exploring Innovations in Cancer Treatment and Research
Publisher: FRONTIERS MEDIA SAISSN: 1970-5557Frequency: 2 issues/year

Oncology Reviews, founded in 2007 and published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to advancing knowledge in the field of oncology and cancer research. With an Impact Factor reflecting its robust engagement in scholarly discourse, this journal maintains a prestigious standing, earning a Q2 ranking in Oncology and a Q3 ranking in Cancer Research as of 2023. Notably, it is indexed in Scopus, where it ranks #118 in Oncology and #98 in Cancer Research, highlighting its global reach and significance. The journal's open-access policy, in effect since 2012, ensures that high-quality research is accessible to all, fostering collaboration and wellness improvements worldwide. This commitment to accessibility and dissemination of pivotal research makes Oncology Reviews an essential resource for researchers, healthcare professionals, and students eager to contribute to and stay abreast of the latest innovations in cancer treatment and research.

Indian Journal of Urology

Advancing Urological Knowledge, One Study at a Time.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-1591Frequency: 4 issues/year

Indian Journal of Urology, published by Wolters Kluwer Medknow Publications, is a premier open-access journal dedicated to the field of urology, serving as a vital platform for researchers and clinicians to disseminate groundbreaking findings since its inception in 2001. With an ISSN of 0970-1591 and an E-ISSN of 1998-3824, this journal has established itself as a crucial resource for advancing knowledge in urological practices, particularly within the Indian context. Recognized in the 2023 Scopus Rankings with a classification of Q3 in Urology, it stands at a significant position (Rank #71 out of 120) with a 41st percentile performance, highlighting its role in contributing to the global discourse in urological medicine. The journal provides open access options, ensuring that high-quality research is readily available to a broad audience, fostering collaboration and innovation. Publishing significant studies from various converged years, including from 1984 to 1999 and more recently from 2006 to 2024, Indian Journal of Urology is essential for professionals seeking to stay updated with the latest advances and best practices in urology.